Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cinnamyl alcohol dehydrogenase (CAD) is a plant enzyme (EC 1.1.1.195) that catalyzes the final NADPH-dependent reduction of cinnamyl aldehydes to their corresponding alcohols—p-coumaryl, coniferyl, and sinapyl alcohols—which are essential precursors for lignin biosynthesis in plant cell walls. As part of the oxidoreductase (short-chain dehydrogenase/reductase, SDR) family, CAD is found in almost all vascular plants, typically as a multigene family with functionally redundant or tissue-specific isoforms. The enzyme plays a crucial role in determining lignin content and composition, influencing plant structural properties and resistance to pathogens and environmental stresses. While vital for plant physiology, there is currently no evidence supporting its direct relevance or targeting in human therapeutic applications.
Enzymatic NADPH-dependent reduction of cinnamyl aldehydes to monolignols (p-coumaryl, coniferyl, and sinapyl alcohols); Genetic inhibition (RNAi, knockouts) leads to altered lignin structure and function in plant studies
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cinnamyl alcohol dehydrogenase (CAD).